|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.4 TWD | -0.40% |
|
-8.86% | -26.05% |
GNT Biotech & Medicals Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 0.63 million. Net loss was TWD 35.86 million compared to TWD 31.27 million a year ago.
Basic loss per share from continuing operations was TWD 1.7 compared to TWD 1.97 a year ago. Diluted loss per share from continuing operations was TWD 1.7 compared to TWD 1.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.05% | 5.85Cr | |
| +21.55% | 4.69TCr | |
| +37.63% | 3.91TCr | |
| -8.00% | 3.85TCr | |
| +29.09% | 3.1TCr | |
| -13.75% | 2.61TCr | |
| +11.12% | 2.59TCr | |
| +36.77% | 1.25TCr | |
| -7.00% | 1.14TCr | |
| -12.58% | 1.06TCr |
GREAT NOVEL THERAPEUTICS BIOTECH & MEDICALS 
